Group financial highlights
|
Summary P&L $ million |
2012 |
2011 |
Change |
|
Revenue |
1,108.7 |
918.0 |
+20.8% |
|
Gross profit |
501.1 |
395.3 |
+26.8% |
|
Gross margin |
45.2% |
43.1% |
+2.1 |
|
Operating profit |
166.8 |
118.7 |
+40.5% |
|
Adjusted operating profit |
193.8 |
145.8 |
+32.9% |
|
Adjusted operating margin |
17.5% |
15.9% |
+1.6 |
|
EBITDA |
225.2 |
165.7 |
+35.9% |
|
Profit attributable to shareholders |
100.3 |
80.1 |
+25.2% |
|
Adjusted1 profit attributable to shareholders |
120.5 |
100.9 |
+19.4% |
|
Earnings per share (cents) |
51.1 |
41.3 |
+23.8% |
|
Dividend per share (cents) |
16.0 |
13.0 |
+23.1% |
|
Net cash flow from operating activities |
182.2 |
126.4 |
+44.1% |
Said Darwazah, Chief Executive Officer of Hikma, said:
"I am pleased with the very strong performance of the Group this year.
In the MENA region, our businesses are thriving as a result of the investment we have been making to strengthen our manufacturing and sales operations and our ongoing commitment to building our businesses in these markets.
Our global Injectables business achieved excellent growth in revenue and profitability, with very strong performances across our geographies. We are benefiting from the strength of our sales and manufacturing platform in the US, strong demand for our products across our markets and our continued track record for quality and operational excellence. We are encouraged by the prospects for the global injectables market and believe the Injectables business is well positioned for strong growth over the medium and long term.
The performance of our Generics business has been impacted by the remediation work we are doing at our Eatontown facility. Following completion of a strategic review, bringing this facility back into regulatory compliance remains the priority, as does returning it to profitability. At the same time, we are evaluating the alternative options for this business.
Our focus in 2013 continues to be on building our business in MENA and on strengthening our global Injectables business. We are well positioned for 2013 and we look forward to another strong year."
